AVBCC 2014 4th Annual Conference
Los Angeles, CA—Major coding changes in cancer tests are ahead, including the elimination of stacked coding and the creation of new codes by the Centers for Medicare & Medicaid Services (CMS), which should improve the clinical application of cancer test choices. Speaking at the Fourth Annual Conference of the Association for Value-Based Cancer Care, Marc Samuels, JD, MPH, President and CEO at ADVI, a healthcare consulting company, Washington, DC, said that value-based testing is important for healthcare cost containment.
Providing Financial Incentives for Patients with Cancer to Participate in Their Care Improves Efficiency
Los Angeles, CA—A new patient incentive program aligns patient behaviors and choices with financial incentives in an effort to reduce the financial burden of cancer care for patients. The program was introduced to attendees at the Fourth Annual Conference of the Association for Value-Based Cancer Care by Gordon Kuntz, Senior Director of Payer Solutions at ION Solutions.
Los Angeles, CA—As more high-cost cancer therapies become available, traditional stop-loss insurance becomes riskier for employers and for payers. Pharmaceutical companies, employers, and benefits design managers are expected to partner to mitigate this economic risk and enhance end-payer coverage for new drugs using the stop-loss risk management tool for self-funded health plans, said Ryan Siemers, CEBS, a risk management insurance expert at Aegis Risk in Alexandria, VA.
Los Angeles, CA—Radical changes are resulting from the recent shift from volume-based to value-based reimbursement and care. The fundamental shift in reimbursement models is proving disruptive, as providers and payers are exploring integration opportunities with their continuum partners that may redefine the current reimbursement paradigm, said Jonathan Bluth, MBA, Vice President, Healthcare Investment Banking, Deloitte Corporate Finance LLC, Los Angeles, CA, at the Fourth Annual Conference of the Association for Value-Based Cancer Care.
Los Angeles, CA—An oncology pathways-based decision-support tool instituted as a collaboration between a payer, oncologists, and other network providers can modify physician behavior that results in cost-savings and reductions in cancer-related inpatient admissions, according to Bruce Feinberg, DO, Vice President and Chief Medical Officer at Cardinal Health Specialty Solutions, Dublin, OH.
Los Angeles, CA—Private exchanges as platforms for employer health insurance plans under the Affordable Care Act (ACA) are growing rapidly —they are already utilized by big corporations and have made some of the biggest strides in the smaller- and medium-sized corporate marketplace. Private health exchanges are already offered by several large global companies, including Walgreens, UPS, Sears, Xerox Corporation, Time Warner, Williams-Sonoma, Panera Bread, and Chico’s.
Los Angeles, CA—The environment for regulation, payment, and healthcare delivery is changing. In particular, disruptive changes in Medicare reimbursement are on the horizon, said Michael E. Meyers, MPH, Managing Director and Head of Investment Banking, T.R. Winston & Company, Los Angeles, at the Fourth Annual Conference of the Association for Value-Based Cancer Care.
Los Angeles, CA—New health insurance benefit designs are being created with various cost levers to help cover expected expenditures. A primer on these designs was offered by Matthew C. Palmgren, PharmD, President, Int’Ovation Healthcare Solutions, at the Fourth Annual Conference of the Association for Value-Based Cancer Care.
Los Angeles, CA—The mission of private exchanges that arose with the passage of the Affordable Care Act (ACA) has employers viewing healthcare as an investment rather than an expense, analyzing the competitors’ healthcare offerings, and holding the employee accountable for its use.
Los Angeles, CA—Can comparative effectiveness research (CER) be used for determining value in cancer care? At the Fourth Annual Conference of the Association for Value-Based Cancer Care, C. Daniel Mullins, PhD, Chairman, Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, discussed this topic (see also article in the September issue of this journal) on the challenges of applying CER into value-based oncology therapy.
Page 1 of 4
Results 1 - 10 of 31
Results 1 - 10 of 31